Print

Acorda Therapeutics (ACOR) Receives Five Awards, Including PM360 Trailblazer Award as Best Specialty Pharma/Biotechnology Company  
10/10/2013 9:44:05 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the Company has recently received five awards recognizing its corporate accomplishments and digital marketing efforts, including the prestigious PM360 Trailblazer Award for Company of the Year in the category of Best Specialty Pharma/Biotechnology Company. The Trailblazer Awards highlight outstanding achievement and innovation in healthcare marketing. In particular, Acorda was recognized for its pursuit of excellence in three separate areas: marketing and advertising, talent development and social responsibility. The award is presented by the widely-read PM360 magazine, a resource for marketing decision-makers in the pharmaceutical, biotech, and medical device industries. Award decisions are made by the PM360 Editorial Advisory Board, composed of distinguished healthcare marketing and other industry experts.

Help employers find you! Check out all the jobs and post your resume.

//-->